DeSantis Damon has filed 8 insider transactions across 2 companies since March 2024.
Most recent transaction: a gift of 1356293 shares of INTEGRATED BIOPHARMA INC ($INBP) on March 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2026 | INTEGRATED BIOPHARMA INC | $INBP | DeSantis Damon | Director | G | Common Stock | 1356293 | $0.00 | 1,356,293.0000 | 31,059,610 | 9999.99% | 4.37% |
| March 24, 2026 | INTEGRATED BIOPHARMA INC | $INBP | DeSantis Damon | Director | G | Common Stock | 7392 | $0.00 | 1,363,685.0000 | 31,059,610 | 0.55% | 0.02% |
| Feb. 27, 2026 | Celsius Holdings, Inc. | $CELH | DeSantis Damon | Director | A | Common Stock, $0.001 par value per share | 2611 | $0.00 | 2,692,187.0000 | 257,785,297 | 0.10% | 0.00% |
| June 18, 2025 | INTEGRATED BIOPHARMA INC | $INBP | DeSantis Damon | Director | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 31,303,011 | 9999.99% | 0.16% |
| March 1, 2025 | Celsius Holdings, Inc. | $CELH | DeSantis Damon | Director | A | Common Stock, $0.001 par value per share | 4865 | $0.00 | 2,689,576.0000 | 235,129,734 | 0.18% | 0.00% |
| Aug. 7, 2024 | INTEGRATED BIOPHARMA INC | $INBP | DeSantis Damon | Director | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 30,873,681 | 9999.99% | 0.16% |
| May 29, 2024 | Celsius Holdings, Inc. | $CELH | DeSantis Damon | Director | G | Common Stock, $0.001 par value per share | 1965988 | $0.00 | 2,684,711.0000 | 0 | 273.54% | 0.00% |
| March 1, 2024 | Celsius Holdings, Inc. | $CELH | DeSantis Damon | Director | A | Common Stock, $0.001 par value per share | 1576 | $0.00 | 718,723.0000 | 0 | 0.22% | 0.00% |